Introduction. Diffuse large B cell lymphoma (DLBCL) is the commonest subtype of non-Hodgkin's lymphoma accounting for approximately 30–50 % of cases [1]. DLBCL shows an aggressive behavior with a median survival of less than 1 year in untreated patients.